Get the Stockscreener App
1.76
2.76%
-0.05
Repare Therapeutics Inc stock is traded at $1.76, with a volume of 90,416.
It is down -2.76% in the last 24 hours and up +12.82% over the past month.
Repare Therapeutics Inc is a precision medicine oncology company focused on the development of synthetic lethality-based therapies for patients with cancer. The Company's focus is the research, development and commercialization of precision oncology drugs targeting specific vulnerabilities of tumors in genetically defined patient populations.
See More
Previous Close:
$1.81
Open:
$1.82
24h Volume:
90,416
Relative Volume:
0.35
Market Cap:
$75.61M
Revenue:
$51.13M
Net Income/Loss:
$-93.80M
P/E Ratio:
-0.7892
EPS:
-2.23
Net Cash Flow:
$-129.10M
1W Performance:
+4.14%
1M Performance:
+12.82%
6M Performance:
+55.75%
1Y Performance:
-41.33%
1-Day Range:
$1.73
$1.82
1-Week Range:
$1.69
$1.82
52-Week Range:
$0.89
$4.0695
Repare Therapeutics Inc Stock (RPTX) Company Profile
Name
Repare Therapeutics Inc
Sector
Industry
Phone
(857) 412-7018
Address
7171 FREDERICK BANTING, SAINT-LAURENT, QC
Compare RPTX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
RPTX
Repare Therapeutics Inc
|
1.76 | 75.61M | 51.13M | -93.80M | -129.10M | -2.23 |
|
VRTX
Vertex Pharmaceuticals Inc
|
394.53 | 99.62B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
465.89 | 61.52B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.00 | 58.91B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
756.38 | 46.69B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
324.34 | 34.54B | 3.81B | -644.79M | -669.77M | -6.24 |
Repare Therapeutics Inc Stock (RPTX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jun-09-23 | Upgrade | Stifel | Hold → Buy |
| Feb-03-23 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jan-06-23 | Initiated | CapitalOne | Overweight |
| Apr-12-22 | Downgrade | Stifel | Buy → Hold |
| Mar-17-22 | Resumed | Goldman | Buy |
| Sep-23-21 | Initiated | Stifel | Buy |
| Sep-13-21 | Initiated | H.C. Wainwright | Buy |
| Jun-28-21 | Initiated | Guggenheim | Buy |
| Mar-01-21 | Initiated | Berenberg | Buy |
| Oct-28-20 | Initiated | Northland Capital | Outperform |
| Jul-14-20 | Initiated | Cowen | Outperform |
| Jul-14-20 | Initiated | Goldman | Neutral |
| Jul-14-20 | Initiated | Morgan Stanley | Overweight |
| Jul-14-20 | Initiated | Piper Sandler | Overweight |
View All
Repare Therapeutics Inc Stock (RPTX) Latest News
News impact scoring models applied to Repare Therapeutics Inc.July 2025 Highlights & Free Verified High Yield Trade Plans - Newser
Applying Elliott Wave Theory to Repare Therapeutics Inc.Weekly Trend Summary & Risk Managed Investment Strategies - Newser
How to forecast Repare Therapeutics Inc. trends using time seriesWeekly Profit Summary & Free Weekly Watchlist of Top Performers - Newser
Is Repare Therapeutics Inc. meeting your algorithmic filter criteriaAnalyst Upgrade & Weekly Watchlist of Top Performers - Newser
Market reaction to Repare Therapeutics Inc.’s recent news2025 Breakouts & Breakdowns & Low Drawdown Momentum Ideas - Newser
Real time breakdown of Repare Therapeutics Inc. stock performanceQuarterly Investment Review & Safe Entry Trade Reports - Newser
Applying Wyckoff theory to Repare Therapeutics Inc. stockEarnings Beat & High Conviction Buy Zone Picks - Newser
Signal strength of Repare Therapeutics Inc. stock in tech scanners2025 Major Catalysts & Real-Time Volume Spike Alerts - Newser
How moving averages guide Repare Therapeutics Inc. trading2025 Stock Rankings & Community Consensus Stock Picks - Newser
Live market analysis of Repare Therapeutics Inc.Market Rally & AI Enhanced Execution Alerts - Newser
Ranking Repare Therapeutics Inc. among high performing stocks via tools2025 EndofYear Setup & Consistent Income Trade Recommendations - Newser
Why Repare Therapeutics Inc. is moving todayPortfolio Gains Report & Safe Swing Trade Setups - Newser
Can you recover from losses in Repare Therapeutics Inc.Market Movers & Risk Controlled Stock Alerts - Newser
Using R and stats models for Repare Therapeutics Inc. forecastingWeekly Loss Report & Real-Time Volume Analysis - Newser
Key resistance and support levels for Repare Therapeutics Inc.Market Activity Report & Fast Moving Trade Plans - Newser
Published on: 2025-09-11 23:07:51 - Newser
Evaluating Repare Therapeutics Inc. with trendline analysis2025 Investor Takeaways & Safe Capital Growth Stock Tips - Newser
Top chart patterns to watch in Repare Therapeutics Inc.GDP Growth & Weekly Chart Analysis and Guides - Newser
How sentiment analysis helps forecast Repare Therapeutics Inc.Trade Exit Report & Safe Capital Growth Plans - Newser
Can volume confirm reversal in Repare Therapeutics Inc.Weekly Market Summary & Fast Entry High Yield Tips - Newser
What momentum shifts mean for Repare Therapeutics Inc.Weekly Stock Analysis & Weekly Top Gainers Trade List - Newser
Can Repare Therapeutics Inc. hit a new high this monthDay Trade & Verified Entry Point Detection - Newser
What data driven models say about Repare Therapeutics Inc.’s futureWeekly Trade Review & Reliable Trade Execution Plans - Newser
What high frequency data says about Repare Therapeutics Inc.Quarterly Earnings Summary & High Yield Stock Recommendations - Newser
What earnings revisions data tells us about Repare Therapeutics Inc.Forecast Cut & Weekly Consistent Profit Watchlists - Newser
Is it time to cut losses on Repare Therapeutics Inc.July 2025 Action & Fast Momentum Stock Entry Tips - Newser
Repare Therapeutics Inc Stock (RPTX) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.93%
0.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):